EMD-33824
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 1)
EMD-33824
Single-particle3.0 Å
Deposition: 13/07/2022Map released: 19/07/2023
Last modified: 25/10/2023
Sample Organism:
Homo sapiens,
Severe acute respiratory syndrome coronavirus 2
Sample: SARS-COV-2 spike glycoprotein in complex with NIV-10
Deposition Authors: Moriyama S
,
Anraku Y ,
Muranishi S,
Adachi Y,
Kuroda D ,
Higuchi Y,
Kotaki R ,
Tonouchi K,
Yumoto K ,
Suzuki T,
Kita S ,
Fukuhara H ,
Kuroda Y,
Yamamoto T,
Onodera T,
Fukushi S,
Maeda K ,
Nakamura-Uchiyama F,
Hashiguchi T ,
Hoshino A ,
Maenaka K ,
Takahashi Y
Sample: SARS-COV-2 spike glycoprotein in complex with NIV-10
Deposition Authors: Moriyama S
,
Anraku Y ,
Muranishi S,
Adachi Y,
Kuroda D ,
Higuchi Y,
Kotaki R ,
Tonouchi K,
Yumoto K ,
Suzuki T,
Kita S ,
Fukuhara H ,
Kuroda Y,
Yamamoto T,
Onodera T,
Fukushi S,
Maeda K ,
Nakamura-Uchiyama F,
Hashiguchi T ,
Hoshino A ,
Maenaka K ,
Takahashi Y
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants.
Moriyama S ,
Anraku Y ,
Taminishi S,
Adachi Y,
Kuroda D ,
Kita S ,
Higuchi Y,
Kirita Y ,
Kotaki R ,
Tonouchi K,
Yumoto K ,
Suzuki T,
Someya T,
Fukuhara H ,
Kuroda Y,
Yamamoto T,
Onodera T,
Fukushi S,
Maeda K ,
Nakamura-Uchiyama F,
Hashiguchi T ,
Hoshino A ,
Maenaka K ,
Takahashi Y
(2023) Nat Commun , 14 , 4198 - 4198
,
Anraku Y ,
Taminishi S,
Adachi Y,
Kuroda D ,
Kita S ,
Higuchi Y,
Kirita Y ,
Kotaki R ,
Tonouchi K,
Yumoto K ,
Suzuki T,
Someya T,
Fukuhara H ,
Kuroda Y,
Yamamoto T,
Onodera T,
Fukushi S,
Maeda K ,
Nakamura-Uchiyama F,
Hashiguchi T ,
Hoshino A ,
Maenaka K ,
Takahashi Y
(2023) Nat Commun , 14 , 4198 - 4198